LMGAX
Price
$28.12
Change
+$0.46 (+1.66%)
Updated
Jul 25 closing price
Net Assets
639.79M
PMAQX
Price
$48.54
Change
+$0.35 (+0.73%)
Updated
Jul 25 closing price
Net Assets
33.21B
Interact to see
Advertisement

LMGAX vs PMAQX

Header iconLMGAX vs PMAQX Comparison
Open Charts LMGAX vs PMAQXBanner chart's image
Lord Abbett Growth Opportunities A
Price$28.12
Change+$0.46 (+1.66%)
VolumeN/A
Net Assets639.79M
Principal MidCap R6
Price$48.54
Change+$0.35 (+0.73%)
VolumeN/A
Net Assets33.21B
LMGAX vs PMAQX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LMGAX vs. PMAQX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMGAX is a Buy and PMAQX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 33.2B vs. LMGAX (640M). PMAQX pays higher dividends than LMGAX: PMAQX (0.19) vs LMGAX (0.00). LMGAX was incepted earlier than PMAQX: LMGAX (30 years) vs PMAQX (9 years). LMGAX (1.15) is less costly to investors than PMAQX (0.59). LMGAX is a more actively managed with annual turnover of: 117.00 vs. PMAQX (10.50). PMAQX has a lower initial minimum investment than LMGAX: PMAQX (0) vs LMGAX (1000). LMGAX annual gain was more profitable for investors over the last year : 35.39 vs. PMAQX (13.98). PMAQX return over 5 years is better than : 58.81 vs. LMGAX (5.79).
LMGAXPMAQXLMGAX / PMAQX
Total Expense Ratio0.960.59163%
Annual Report Gross Expense Ratio1.150.59195%
Fund Existence30 years9 years-
Gain YTD10.9278.761125%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets640M33.2B2%
Annual Yield % from dividends0.000.19-
Returns for 1 year35.3913.98253%
Returns for 3 years50.2950.8499%
Returns for 5 years5.7958.8110%
Returns for 10 years25.14N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHSCP27.720.17
+0.62%
CHS
NLOP33.420.19
+0.57%
Net Lease Office Properties
CLDX23.350.13
+0.56%
Celldex Therapeutics
MUR26.13-0.20
-0.76%
Murphy Oil Corp
IPSC0.63-0.03
-5.17%
Century Therapeutics